Genomic landscape of urothelial cancer (UC), chemotherapy (CTX) response, and outcome based on smoking status.

Monali K. Vasekar,Hamid Emamekhoo,Petros Grivas,JoAnn Hsu,Sierra Min Li,Junjia Zhu,Arnab Basu,Joseph J. Drabick,Sheldon L. Holder,Joshua I. Warrick,Matthew Kaag,Garrett M. Frampton,Siraj M. Ali,Vincent A. Miller,Jeffrey S. Ross,Sumanta K. Pal,Monika Joshi

Genomic landscape of urothelial cancer (UC), chemotherapy (CTX) response, and outcome based on smoking status.

2016

Monali K. Vasekar
Hamid Emamekhoo
Petros Grivas
JoAnn Hsu
Sierra Min Li
Junjia Zhu
Arnab Basu
Joseph J. Drabick
Sheldon L. Holder
Joshua I. Warrick
Matthew Kaag
Garrett M. Frampton
Siraj M. Ali
Vincent A. Miller
Jeffrey S. Ross
Sumanta K. Pal
Monika Joshi

e16030Background: Smoking has a strong association with UC but never-smokers can also get UC. We studied the genomic alterations in pts with UC along with their clinicopathological features and out...

Keywords:

Pathology
Cancer
Chemotherapy
Medicine
smoking status
clinicopathological features
urothelial cancer
Internal medicine
Oncology

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations